Singapore’s core inflation moderated further in August from a year ago, reflecting improvements to supply chains and lower import costs that allow the central bank room to extend its pause on monetary tightening.
India’s $1 trillion government bond market has struggled for years to rise above the criticism of being insular.
Eisai Co.’s breakthrough Alzheimer’s disease drug won clearance from Japanese regulators after the medicine was fully cleared in the US in July.
Just a couple of months ago, emerging-market assets were all the rage as inflation eased and interest rate-cut bets surfaced. The trade has all but fizzled out.
India is loosening its planned restrictions on imports of laptops, tablets and other IT hardware, giving manufacturers such as Apple Inc., HP Inc. and Dell Technologies Inc. more time to prepare for potential curbs.
Hedge funds catapulted bearish wagers on the euro to a near one-year high as markets bet the European Central Bank is done raising interest rates.
Overseas investors continue to shun Philippine equities, unloading more than $370 million in a 24-day selling streak that helped sink the Philippine Stock Exchange Index to a 3.5% slump, the worst in Southeast Asia. Withdrawals in the five-week period through Friday pushed this year’s outflow to more than $552 million.
Investors have about $2 trillion of funds available to invest, and about $100 billion to $150 billion of that is focused on India, according to Anu Aiyengar, JPMorgan Chase & Co.’s global head of mergers and acquisitions.
Thailand’s baht may be poised for a rebound as analysts bet that growth measures announced by newly appointed Prime Minister Srettha Thavisin will bear fruit.
A subterranean space once used by British spies has been sold to fund manager Angus Murray, who has grand ambitions for it.
